Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2023 annual report, the company imports pharmaceutical medicines and cosmetic products into Georgia and sells them through pharmacy networks and wholesale.
| Line item | 2022 | 2023 | CAGR |
|---|---|---|---|
| 4,532 | 1,384 | -69.5% | |
| 1,173 | 553 | -52.9% | |
| TOTAL ASSETS | 5,705 | 1,936 | -66.1% |
| 4,061 | 2,043 | -49.7% | |
| Total Non-Current Liabilities | 1,199 | 1,580 | +31.8% |
| TOTAL LIABILITIES | 5,260 | 3,624 | -31.1% |
| 445 | 1,688 | nmf | |
| Balance Check (Assets - L&E) | 0 | 0 | |
| Debt analysis | |||
| Total Debt | 1,199 | 1,580 | +31.8% |
| Cash & Equivalents | 332 | 38 | -88.6% |
| Net Debt | 867 | 1,542 | +77.9% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →